Background & aims The incidence of inflammatory bowel disease (IBD) is increasing
internationally, particularly in nations with historically low rates. Previous reports of the …

AIM To perform a comprehensive review and provide an up-to-date synopsis of the
incidence and trends of inflammatory bowel disease (IBD). METHODS We systematically …

Background & Aims Inflammatory bowel diseases (IBDs) exist worldwide, with high
prevalence in North America. IBD is complex and costly, and its increasing prevalence …

Background The latest estimate of the prevalence of inflammatory bowel disease (IBD) in the
United States was based on 2009 data, which indicates a need for an up-to-date re …

Inflammatory bowel diseases (IBD) are currently considered multifactorial pathologies in
which various combined environmental factors act on a genetic background, giving rise to a …

Antibiotic use is increasing worldwide. However, the use of antibiotics is clearly associated
with changes in gut microbiome composition and function, and perturbations have been …

Canada has among the highest incidence and prevalence of inflammatory bowel disease
(IBD) in the world. After decades of rising incidence of IBD in Canada during the 20th …

Very early onset inflammatory bowel disease (VEO-IBD) is defined as IBD presenting before
6 years of age. When compared with IBD diagnosed in older children, VEO-IBD has some …

Background Early life exposures impact immune system development and therefore the risk
of immune-mediated diseases, including inflammatory bowel disease (IBD). We …

Importance Inflammatory bowel diseases (IBD), such as Crohn disease and ulcerative
colitis, are chronic relapsing conditions that affect a growing number of children worldwide …